Imaging of Neuroendocrine Prostatic Carcinoma

Area of Science:

• Oncology
• Urology
• Radiology

Background:

• Neuroendocrine prostate cancer (NEPC) is an aggressive prostate cancer subtype with high metastatic potential and poor prognosis.
• NEPC can arise de novo but commonly develops as a treatment resistance mechanism in conventional prostatic adenocarcinoma, also known as castration-resistant prostate cancer (CRPC).
• The incidence of NEPC increases after hormonal therapy, presenting diagnostic and clinical management challenges.

Purpose of the Study:

• To provide a comprehensive imaging review of prostatic neuroendocrine tumors.
• To highlight the diagnostic challenges associated with NEPC.
• To discuss the clinical management of NEPC.

Main Methods:

• Review of imaging modalities used for prostatic neuroendocrine tumors.
• Analysis of radiological and pathological diagnostic features of NEPC.
• Discussion of clinical management strategies.

Main Results:

• NEPC presents unique imaging characteristics.
• Radiological and pathological diagnosis of NEPC can be challenging.
• Effective clinical management requires specialized approaches.

Conclusions:

• NEPC is a distinct and challenging entity in prostate cancer management.
• Comprehensive imaging review is crucial for diagnosis and management.
• Further research into NEPC imaging and treatment is warranted.